A study presented at American Headache Society Annual Scientific Meeting; June 19-22, 2025; Minneapolis has revealed that ...

Treatment needs vary among patients with cluster headache, according to a poster presented at the American Headache Society ...

Erenumab is not associated with significant reductions in weekly attacks in patients with chronic cluster headache vs placebo ...

Eptinezumab use improves quality-of-life measures but does not significantly reduce the number of episodic cluster headache attacks in early trial weeks. News & Perspective Tools & Reference CME/CE.

Nummular headache is a rare headache disorder marked by a coin-shaped pain on the scalp. Learn how it differs from other headache types, how it's diagnosed, and treatment options.

For those with episodic migraine, data shows that almost 88% of people studied had fewer headache days. The same study found that CGRP inhibitors significantly reduced the number of headache days ...

Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency. https://headachejournal ...

Explore effective chronic migraine treatments, including medications, supplements, devices, and natural options. Discover how to manage migraine and improve your quality of life.

Frequent episodic tension headache: The IHS states that a person will experience no fewer than 10 headaches a month, occurring between 1 to 14 days per month, for 3 months or more.

Episodic cluster headaches occur repeatedly over 2 weeks to 3 months. ... Post-traumatic headache: A review of prevalence, clinical features, risk factors, and treatment strategies. https: ...

Atogepant 60 mg vs rimegepant and galcanezumab for episodic migraine prevention has superior efficacy, with comparable safety ...

With historical data showing migraine to be underdiagnosed and undertreated, new guidance from the American College of Physicians (ACP) encompasses 3 recommendations on treating episodic migraine ...